Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.5%

173 terminated/withdrawn out of 2657 trials

Success Rate

91.2%

+4.7% vs industry average

Late-Stage Pipeline

9%

246 trials in Phase 3/4

Results Transparency

42%

757 of 1796 completed trials have results

Key Signals

422 recruiting757 with results113 terminated60 withdrawn

Enrollment Performance

Analytics

N/A
1308(61.3%)
Phase 2
365(17.1%)
Phase 1
169(7.9%)
Phase 3
127(6.0%)
Phase 4
119(5.6%)
Early Phase 1
45(2.1%)
2133Total
N/A(1308)
Phase 2(365)
Phase 1(169)
Phase 3(127)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2657)

Showing 20 of 2657 trials
NCT05639088Not ApplicableActive Not Recruiting

Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes

Role: collaborator

NCT05193981Active Not Recruiting

A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD

Role: collaborator

NCT06991738Phase 1Not Yet Recruiting

177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Role: lead

NCT07444723Phase 2Recruiting

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

Role: lead

NCT05722210Not Yet Recruiting

Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant

Role: lead

NCT01712620Phase 2Recruiting

Spironolactone for Pulmonary Arterial Hypertension

Role: collaborator

NCT06690294Not Yet Recruiting

Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism

Role: lead

NCT07388537Not Yet Recruiting

Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults

Role: lead

NCT05713799Phase 2Not Yet Recruiting

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

Role: lead

NCT04860336Completed

Glycemic Observation and Metabolic Outcomes in Mothers and Offspring

Role: collaborator

NCT02019706Phase 2Recruiting

Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome

Role: lead

NCT05735743Not ApplicableActive Not Recruiting

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

Role: collaborator

NCT05095532Phase 1Recruiting

Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT

Role: collaborator

NCT07191561Not Yet Recruiting

Hepatic Lipid Metabolism-Alcohol Use Disorder

Role: lead

NCT07313787Phase 2Not Yet Recruiting

Effects of Meal Macronutrients on Postprandial Lipids

Role: lead

NCT02910531Phase 2Completed

Lipoic Acid Supplement for Cystine Stone

Role: collaborator

NCT06925776Not ApplicableRecruiting

Community Health Workers in an Interdisciplinary Outpatient CKD Clinic to Optimize Social Care Navigation, Patient Engagement, and Home Dialysis Utilization

Role: collaborator

NCT05067621Phase 2Active Not Recruiting

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

Role: collaborator

NCT06730113Recruiting

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

Role: lead

NCT07516509Not Yet Recruiting

Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance

Role: collaborator